IL-3 gene therapy (Crucell)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIL-3 gene therapy (Crucell)
Drug Alias NameIL-3 gene therapy (IntroGene)
ClassificationBiologics
Mechanisms of ActionInterleukin-3 stimulants
TargetsInterleukin-3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCrucell NV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCrucell NV
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A